{
    "RADCURE-0359": {
        "question": "Age: 76.4, Sex: Male, ECOG PS: ECOG 1, Smoking PY: 0, Smoking Status: Non-smoker, Ds Site: Esophagus, Subsite: Cervical esophagus, T: T2, N: N1, M : M0, Stage: III, Path: Squamous Cell Carcinoma, HPV: none, Tx Modality: RT alone, Chemo? : none, Dose: 70.0, Fx: 35, Local: none, Regional: Yes, Distant: none, 2nd Ca: S   (suspicious), ContrastEnhanced: 1\nAnswer: ",
        "recruit-recruiter": "1. Radiation Oncologist - Your expertise is strictly limited to radiation therapy planning and dosing for esophageal squamous cell carcinoma, especially in cervical esophagus cases without chemotherapy. - Hierarchy: Radiation Oncologist",
        "initial_assessment-radiation oncologist": "Step-by-step analysis as a radiation oncologist:\n\n1. The CT scan is a sagittal view of the head and neck region, showing the cervical spine, airway, and soft tissues of the neck.\n2. The provided bounding box coordinates are identical: [265, 236, 129, 265, 278, 164]. This suggests a very small or possibly zero-volume region, which may be an error or a very localized ROI.\n3. The ROI appears to be located in the cervical esophagus region, given the anatomical landmarks visible (vertebrae, airway).\n4. No obvious gross tumor mass or abnormal soft tissue density is visible within the ROI on this single slice. The esophageal lumen appears patent.\n5. No evident invasion into adjacent structures such as the airway or vertebral bodies is seen.\n6. From a radiation oncology perspective, the absence of gross visible tumor on this slice does not exclude microscopic disease or regional lymph node involvement.\n7. The clinical data (not provided here) would be essential to correlate with imaging for staging and treatment planning.\n8. Given the cervical esophagus location, careful radiation planning is needed to avoid critical structures like the spinal cord and airway.\n9. Without visible gross tumor or nodal disease in this ROI, the prognosis may be more favorable if the disease is limited and treated with definitive radiation.\n10. However, the small or zero-volume ROI limits detailed assessment of tumor burden or extent.\n\nFinal conclusion: Based on the imaging alone, no visible gross tumor or abnormality is identified in the ROI. Prognosis depends on clinical staging and treatment response.\n\nAnswer: Alive",
        "initial_assessment_review_assessment-radiation oncologist": "Answer:Alive",
        "Round 1-role-comment": "radiation oncologist:alive",
        "Round 1-num_agents": 1,
        "Round 2-Turn 1-discuss-participate_review_assessment-radiation oncologist": "Answer:no  \nAlive",
        "Round 2-Turn 1-ask_gap_review_assessment-radiation oncologist": "---\nAnswer: yes\nReason: Suspicion of second primary cancer requires multidisciplinary input (e.g., medical oncologist, surgeon).\n---",
        "Round 2-Turn 1-gap_identified-assistant": "- Consult a medical oncologist for evaluation and management of the suspicious second primary cancer.  \n- Involve a surgeon to assess the suspicious second primary cancer and consider surgical options if appropriate.",
        "Round 2-Turn 1-gap_recruit-recruiter": "1. Medical Oncologist - Your expertise is strictly limited to evaluation and management of suspicious second primary cancers and systemic therapy considerations in esophageal squamous cell carcinoma. - Hierarchy: Medical Oncologist == Radiation Oncologist  \n2. Surgical Oncologist (Recurrence/Secondary Cancers) - Your expertise is strictly limited to assessing surgical options for suspicious second primary cancers in esophageal squamous cell carcinoma patients. - Hierarchy: Surgical Oncologist == Radiation Oncologist",
        "Round 2-Turn 1-gap_recruited_assessment-medical oncologist": "The provided bounding box coordinates [[265, 236, 129, 265, 278, 164], [265, 236, 129, 265, 278, 164]] appear to be identical, indicating a single region of interest within the head and neck CT scan. This region is located in the cervical area, likely encompassing part of the cervical esophagus or adjacent structures.\n\nFrom a medical oncologist's perspective, focusing on esophageal squamous cell carcinoma (SCC) in the cervical esophagus, the highlighted region may represent the primary tumor or a suspicious second primary cancer (2nd Ca: S). The scan shows involvement consistent with T2 (tumor invades muscularis propria) and N1 (regional lymph node metastasis), without distant metastasis (M0). The patient is treated with radiotherapy alone (70 Gy in 35 fractions), without chemotherapy.\n\nGiven the patient's age (76.4 years), ECOG performance status 1, non-smoker status, and localized disease with regional nodal involvement, the prognosis is guarded but potentially favorable with definitive radiotherapy. The presence of a suspicious second primary cancer in the same region may complicate management but does not necessarily preclude survival.\n\nConsidering these factors, the patient's survival probability is cautiously optimistic, especially with adequate local and regional control.\n\n('Answer:Alive',)",
        "Round 2-Turn 1-gap_recruited_assessment_review_assessment-medical oncologist": "The patient is a 76.4-year-old male with localized cervical esophageal squamous cell carcinoma (T2N1M0, Stage III), treated with definitive radiotherapy (70 Gy/35 fractions) without chemotherapy. Key considerations:  \n- **Non-smoker status**: Reduces competing risks but does not eliminate esophageal SCC progression.  \n- **ECOG PS 1**: Supports tolerability of aggressive RT but may have influenced the omission of chemotherapy.  \n- **Radiotherapy alone**: Suboptimal compared to concurrent chemoradiation (standard for Stage III), potentially increasing recurrence risk.  \n- **Suspicious second primary (2nd Ca: S)**: Requires biopsy confirmation; if confirmed, prognosis worsens due to multifocal disease burden.  \n- **T2/N1 disease**: Moderate locoregional control with RT alone; nodal involvement elevates recurrence risk.  \n- **Age and comorbidities**: May limit salvage options if recurrence occurs.  \n\nDespite the absence of distant metastasis and adequate RT dosing, the lack of systemic therapy and potential second primary suggest a guarded prognosis. However, in the absence of overt progression or confirmed metastatic disease, short-term survival is plausible.  \n\nAnswer:Alive",
        "Round 2-Turn 1-gap_recruited_assessment-surgical oncologist (recurrence/secondary cancers)": "Step-by-step analysis as a surgical oncologist (recurrence/secondary cancers):\n\n1. **Anatomical structures and ROI**: The bounding box coordinates [[265, 236, 129, 265, 278, 164], [265, 236, 129, 265, 278, 164]] appear to be identical, indicating a single region of interest within the head and neck CT scan. The coordinates suggest a localized volume in the cervical esophagus region, consistent with the primary tumor site.\n\n2. **Visible patterns/abnormalities**: The CT image shows a contrast-enhanced sagittal view of the cervical esophagus with a highlighted region (blue mask) corresponding to the tumor. The tumor appears to involve the esophageal wall with possible regional lymph node involvement (N1). No distant metastases (M0) are visible in this scan.\n\n3. **Clinical context**: The patient is a 76.4-year-old male with ECOG 1, non-smoker, diagnosed with stage III cervical esophageal squamous cell carcinoma (T2N1M0). Treatment was radiotherapy alone (70 Gy in 35 fractions) without chemotherapy. There is suspicion of a second primary cancer (2nd Ca: S).\n\n4. **Surgical oncologist perspective on survival and recurrence**: \n   - Cervical esophageal squamous cell carcinoma with regional nodal involvement (N1) and no distant metastasis (M0) has a guarded prognosis.\n   - Radiotherapy alone without chemotherapy may be suboptimal for locoregional control, increasing risk of recurrence.\n   - The presence of a suspicious second primary cancer raises concern for additional morbidity and complicates management.\n   - Surgical options may be limited due to tumor location and patient age, but careful evaluation for salvage surgery or resection of second primary lesions is warranted.\n   - Overall survival probability is moderate but compromised by nodal disease and second primary suspicion.\n\nFinal answer:\n\n('Answer:Dead',)",
        "Round 2-Turn 1-gap_recruited_assessment_review_assessment-surgical oncologist (recurrence/secondary cancers)": "('Answer:Dead',)",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate_review_assessment-medical oncologist": "Answer:Alive",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate_review_assessment-surgical oncologist (recurrence/secondary cancers)": "Answer:Dead",
        "Round 2-role-comment": "radiation oncologist:alive|medical oncologist:alive|surgical oncologist (recurrence/secondary cancers):dead",
        "Round 2-num_agents": 3,
        "num_cooperations-panel": 0,
        "decision-Moderator": "('Answer: Dead',)"
    }
}